European Research Council grant · Running
Cyclo-warhead New chemical warheads for covalent drug discovery
- Coordinator
- Fundacio Institut Catala D'investigacio Quimica, Spain
- Runs
- 1 January 2025 to 30 June 2026
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101189468
What the project is doing
In the project's own words, from its summary on CORDIS.
Over the past two decades, the pharmaceutical industry has witnessed an exponential growth in approved covalent drugs. The majority of such drugs incorporate a chemical warhead, a mild electrophilic reactive functional group that forms covalent bonds in a reversible or irreversible manner with nucleophilic aminoacid residues. The aim of this proposal is to assess the viability of a new chemical warhead in the discovery of novel kinase inhibitors.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fundacio Institut Catala D'investigacio Quimica | Tarragona | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI